0 Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical ScienceSeptember 22, 2020 READ MORE
0 Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember, 15, 2020 READ MORE
1 Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease TherapeuticsJuly 28, 2020 READ MORE
0 Axial Biotherapeutics to Present at the Jefferies Virtual Global Healthcare ConferenceMay 27, 2020 READ MORE
0 Axial Biotherapeutics to Present Virtual Presentation at American Society of Clinical Psychopharmacology (ASCP) 2020 Annual MeetingMay 22, 2020 READ MORE
2 Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum DisorderApril 02, 2020 READ MORE
0 Axial Biotherapeutics to Present at the Chardan 2nd Annual Microbiome Medicines Virtual SummitMarch 10, 2020 READ MORE
0 Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership TeamFebruary 12, 2020 READ MORE
1 Axial Biotherapeutics to Present at the Centre for Clinical Trials in Rare Neurodevelopmental Disorders’ Emerging Management Therapies for Childhood Neurodevelopmental Disorders Scientific SymposiumFebruary 5, 2020 READ MORE
